Skip to content
Saturday, June 7, 2025
Latest:
  • Learning that lifts us all: Insights from a year of growth and professional development
  • A novel source of genetic variation influencing childhood brain tumors
  • Beyond the operating room: How international training elevates orthopedic care
  • Innovation resident plays key role in groundbreaking heart device research
  • Alzheimer’s disease affects an organism as a whole
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu
A doctor holding a clipboard speaks to a patient.
From The Labs

SQUID increases accessibility to single-cell tumor profiling to improve treatment outcomes

August 22, 2023 bulk RNA analysis,  Cancer,  chemoresistant,  chemosensitive,  improved treatment outcome,  personalized medicine,  Research,  scRNA-seq,  SQUID,  tumor profiling

This innovative approach would make single-cell RNA sequencing analyses more accessible, enabling doctors to personalize treatment decisions in efforts to improve the outcomes for their patients.

Read More
From The Labs

An unprecedented look at endometrial cancer

February 20, 2020 endometrial cancer,  personalized medicine,  proteogenomics,  Research,  uterine cancer

Which therapy will benefit this particular patient the most? Dr. Bing Zhang and his colleagues offer insights that might help physicians better answer this question

Read More
From The Labs

A roadmap for coordinating future efforts in precision medicine

August 27, 2019 BCM Human Genome Sequencing Center,  clinical reporting,  personalized medicine,  precision medicine,  Research

Baylor College of Medicine is part of a National Institutes of Health four-year study to harmonize and standardize clinical genetic reporting. The study has produced

Read More
From The Labs

What activates the PI3K pathway, the most commonly mutated pathway in cancer that can be targeted by drugs?

July 31, 2017 cancer mutations,  Cancer pathways,  IDH1 gene,  personalized medicine,  PI3K pathway,  The Cancer Genome Atlas,  VHL gene

The PI3K pathway has a number of diverse functions, including altering the cell’s metabolism and driving cell growth and proliferation. The PI3K pathway also is

Read More

From the Labs: Image of the Month

Blood vessels (magenta) intertwined with metastatic medulloblastoma tumor cells (green) nestled within the protective layers that surround the mouse spinal cord. From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951